Tuberculosis/HIV Coinfection and Treatment Trends-China, 2015−2019  

作　　者：Eryong Liu Qian Wang Guoqin Zhang Lin Zhou Mingting Chen 

机构地区：[1]National Center for Tuberculosis Control and Prevention,China CDC,Beijing,China [2]Tianjin Center for Tuberculosis Control,Tianjin,China

出　　处：《China CDC weekly》2020年第48期924-928,共5页中国疾病预防控制中心周报（英文）

摘　　要：Introduction:New data has become available on the implementation of tuberculosis/human immunodeficiency virus(TB/HIV)two-way screening and anti-TB treatment for TB/HIV coinfected patients in China from 2015 to 2019,which can be used to propose key strategies for further TB/HIV prevention and treatment.Methods:The report on TB/HIV coinfection in the mainland of China from 2015 to 2019 was collected to compare the annual trend and the rate of geographical distribution.Results:From 2015 to 2019,the proportion of TB screening using chest x-ray or sputum examination among HIV-positive people increased from 79.8%to 88.0%(p<0.01).The proportion ranged from 40.7%to 97.1%among various provincial-level administrative divisions(PLADs),with a median of 87.3%.TB prevalence among HIV-positive people decreased from 1.1%to 0.8%(p<0.01)over the 5 years.The proportion of HIV testing among TB patients increased from 46.0%to 64.0%(p<0.01).The prevalence of HIV among TB patients increased from 0.8%to 1.1%(p<0.01).The success rate of anti-TB treatment for TB/HIV patients was 87.6%,and the primary reason for unsuccessful treatment were death(5.3%)and other reason such as availability of only basic treatment options(5.0%).Conclusions and Implications for Public Health Practice:TB/HIV two-way screening in China improved significantly during the 5-year period,however there were large regional differences and gaps in target HIV-screening rates among TB patients,suggesting that two-way screening in some PLADs and the HIV screening among TB patients should be strengthened.Early diagnosis,early treatment,and treatment management of TB/HIV patients should also be strengthened.

关 键 词：PREVENTION diagnosis treatment 

分 类 号：R52[医药卫生—内科学] R512.91[医药卫生—临床医学]